Sun, Aug 31, 2014, 5:36 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • fudfighter4 fudfighter4 Feb 20, 2013 2:00 PM Flag

    A question arguably unworthy of consideration?

    From another toxicity study -

    "The chronic oral toxicity of propiverine hydrochloride (P-4), a new anti-pollakiuria agent, was studied in beagle dogs. Groups of 6 males and 6 females were treated with P-4 at doses of 0, 0.3, 1, 3, 9 mg/kg/day for one year and thereafter 2 animals of both sexes in each group were placed on withdrawal for one month."

    Insmed's dog toxicity study was initiated last April. If it was initiated during the first week in April, the process of data collection and analysis from the dogs which didn't participate in the recovery phase would presumably have started about six weeks ago.

    Would that allow sufficient time for data to leak out?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
13.93+0.11(+0.80%)Aug 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.